Korean J Radiol.  2007 Jun;8(3):212-215. 10.3348/kjr.2007.8.3.212.

Chronic Extrahepatic Bile Duct Dilatation: Sonographic Screening in the Patients with Opioid Addiction

• Farahmand
• PourGholami M
• Fathollah

• KMID: 1779436
• DOI: http://doi.org/10.3348/kjr.2007.8.3.212

Abstract

OBJECTIVE
One of the best known side effects of using opium is spasm of the sphincter of Oddi, which may increase the diameter of the extrahepatic bile ducts. Ultrasound is the first imaging modality used for evaluating the biliary system because it is commonly available and noninvasive. The principal objective of this study was to measure the common bile duct (CBD) diameter via ultrasonography in opium addicts and to evaluate the relation between the CBD diameter and the period of addiction. MATERIALS AND METHODS: This research was an analytical-cross sectional study that was done on 110 opium addicts that were admitted to a drug treatment center. The diameter of the CBD in these cases was measured by ultrasonography and the results were analyzed with other factors like age, the period of addiction and the laboratory findings. RESULTS: According to the findings, there is a significant increase in the range of the CBD diameter in comparison with normal bile ducts. Also, the mean diameter of the CBD in the different age groups showed a significant difference (p < 0.0001) and there was a significant relation between the CBD diameter and the period of addiction (p < 0.001, r = 0.74); so, with the increased length of the addiction period, the mean CBD diameter increases. CONCLUSION: Opium addiction is one of the factors that causes extrahepatic bile duct dilatation, so in these cases, if no obstructing lesion was found on ultrasound examination and the serum bilirobine and alkaline phosphatase levels are normal, then further evaluation is not needed.

Keyword

Ultrasonography (US); Common bile duct; Addiction, and opium

MeSH Terms

Adult
Age Factors
Aged
Chronic Disease
Common Bile Duct/*ultrasonography
Common Bile Duct Diseases/*ultrasonography
Cross-Sectional Studies
Dilatation, Pathologic/ultrasonography
Humans
Middle Aged
Opioid-Related Disorders/*complications
Time Factors

Reference

1. Berezny GM, Beck IT, DaCosta LR, O'Brien PG, Paloschi GB. Ultrasound in the diagnosis of sphincter of Oddi spasm. J Clin Gastroenterol. 1985. 7:528–532.

2. Rumack CM, Wilson SR, Charboneau JW. Diagnostic ultrasound. 1988. 2nd ed. St. Louis: Mosby;207.

3. Katznug BG. Basic & Clinical pharmacology. 2001. 8th ed. New York: McGraw-Hill;521.

4. Hardman JG, Limbird LE. Goodman & Gilman's the pharmacological basis of therapeutics. 2001. 10th ed. New York: McGraw-Hill;585.

5. Kaihlenen PM. The complete drug reference. 1999. 32nd ed. Boston: Pharmaceutical Press;68.

6. Butler KC, Selden B, Pollack CV Jr. Relief by naloxone of morphine-induced spasm of the sphincter of Oddi in a post-cholecystectomy patient. J Emerg Med. 2001. 21:129–131.

7. Zylberberg H, Fontaine H, Correas JM, Carnot F, Brechot C, Pol S. Dilated bile duct in patients receiving narcotic substitution: an early report. J Clin Gastroenterol. 2000. 31:159–161.

8. Wu SD, Zhang ZH, Jin JZ, Kong J, Wang W, Zhang Q, et al. Effect of narcotic analgesic drugs on human Oddi's sphincter motility. World J Gastroenterol. 2004. 10:2901–2904.

9. Wu SD, Kong J, Wang W, Zhang Q, Jin JZ. Effect of morphin and M-cholinoceptor bloching drugs on human sphincter of Oddi during choledochofiberoscopy manometry. Hepatobiliary Pancreat Dis Int. 2003. 2:121–125.

10. Sharma SS. Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity. Gastrointest Endosc. 2002. 55:427–430.

11. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001. 96:1266–1272.

12. Barlas D, Margouleff D, Vignogna-Barlas L, Lesser ML. Opioids prolong nuclear hepatobiliary imaging when given prior to scaning. J Emerg Med. 2002. 23:231–236.